Speaker illustration

Doctor Cristina Chimenti

Sapienza University of Rome, Rome (Italy)

Long-term clinical-pathologic results of enzyme replacement therapy in pre-hypertrophic fabry disease cardiomyopathy.

Event: ESC Congress 2024

Topic: Pathophysiology and Mechanisms

Session: New insights into pharmacotherapy for acute heart failure

Thumbnail

Treatment of virus negative chronic myocarditis: Long term follow-up of TIMIC trial

Event: ESC Congress 2020

Topic: Myocarditis

Session: Myocardial Disease ePosters

Thumbnail

Hypertrophy of unaffected cardiomyocytes concurs to severity of cardiomyopathy in female patients with Fabry disease

Event: ESC Congress 2018

Topic: Infiltrative Myocardial Disease

Session: Cardiomyopathy in Fabry disease

Thumbnail

Telomere shortening in human hypertrophic cardiomyopathy

Event: Heart Failure 2018

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial Disease – Clinical

Thumbnail

Immune-mediated myocarditis in fabry disease cardiomyopathy

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Myocarditis

Session: Cardiomyopathy

Thumbnail

Myocardial regeneration in human hypertrophic cardiomyopathy

Event: ESC Congress 2016

Topic: Cardiomyopathies

Session: Cardiomyopathy

Thumbnail

Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus negative inflammatory cardiomyopathy

Event: ESC Congress 2016

Topic: Myocarditis

Session: Best Posters in myocarditis

Thumbnail